Taken together, our data suggest that leptin doses mimicking hyperleptinemia in individuals with obesity were able to activate NCOA1, contributing to the activation and phosphorylation of the JAK2/STAT3 pathway. The gene discussed is STAT3; the disease is obesity disorder.